{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:32:57Z","timestamp":1792791177156,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102480"],"award-info":[{"award-number":["82102480"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Postdoctoral Research Funding Project of Jiangsu Province","award":["2021K012A"],"award-info":[{"award-number":["2021K012A"]}]},{"name":"Jiangsu Provincial Research Hospital","award":["YJXYY202204-ZD06"],"award-info":[{"award-number":["YJXYY202204-ZD06"]}]},{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX24_3583"],"award-info":[{"award-number":["KYCX24_3583"]}]},{"name":"the project of Nantong Science and Technology Bureau","award":["JC2023108"],"award-info":[{"award-number":["JC2023108"]}],"id":[{"id":"https:\/\/ror.org\/02tx34m84","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-80592-y","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T02:09:16Z","timestamp":1732154956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identification of serum tsRNA-Thr-5-0015 and combined with AFP and PIVKA-II as novel biomarkers for hepatocellular carcinoma"],"prefix":"10.1038","volume":"14","author":[{"given":"Kangfeng","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinran","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bairong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuihua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"80592_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet, J. M. et al. Hepatocellular carcinoma. Nat Rev Dis Primers 7, 6 (2021).","journal-title":"Nat Rev Dis Primers"},{"key":"80592_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s13046-019-1396-4","volume":"38","author":"Y Fu","year":"2019","unstructured":"Fu, Y., Liu, S., Zeng, S. & Shen, H. From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma. J Exp Clin Cancer Res 38, 396 (2019).","journal-title":"J Exp Clin Cancer Res"},{"key":"80592_CR3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.crad.2017.01.013","volume":"72","author":"L Crocetti","year":"2017","unstructured":"Crocetti, L., Bargellini, I. & Cioni, R. Loco-regional treatment of HCC: Current status. Clin Radiol 72, 626\u2013635 (2017).","journal-title":"Clin Radiol"},{"key":"80592_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cca.2016.10.006","volume":"463","author":"C Sauzay","year":"2016","unstructured":"Sauzay, C. et al. Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma. Clin Chim Acta 463, 39\u201344 (2016).","journal-title":"Clin Chim Acta"},{"key":"80592_CR5","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1002\/cam4.2968","volume":"9","author":"Y Ding","year":"2020","unstructured":"Ding, Y. et al. Combination of inflammatory score\/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma. Cancer Med 9, 3057\u20133069 (2020).","journal-title":"Cancer Med"},{"key":"80592_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12885-021-08138-3","volume":"21","author":"H Feng","year":"2021","unstructured":"Feng, H., Li, B., Li, Z., Wei, Q. & Ren, L. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. BMC Cancer 21, 401 (2021).","journal-title":"BMC Cancer"},{"key":"80592_CR7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/hon.2616","volume":"37","author":"P Karousi","year":"2019","unstructured":"Karousi, P. et al. Identification of a novel tRNA-derived RNA fragment exhibiting high prognostic potential in chronic lymphocytic leukemia. Hematol Oncol 37, 498\u2013504 (2019).","journal-title":"Hematol Oncol"},{"key":"80592_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.canlet.2019.03.012","volume":"452","author":"L Zhu","year":"2019","unstructured":"Zhu, L., Ge, J., Li, T., Shen, Y. & Guo, J. tRNA-derived fragments and tRNA halves: The new players in cancers. Cancer Lett 452, 31\u201337 (2019).","journal-title":"Cancer Lett"},{"key":"80592_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13046-021-01836-7","volume":"40","author":"EW Tao","year":"2021","unstructured":"Tao, E. W. et al. A specific tRNA half, 5\u2019tiRNA-His-GTG, responds to hypoxia via the HIF1\u03b1\/ANG axis and promotes colorectal cancer progression by regulating LATS2. J Exp Clin Cancer Res 40, 67 (2021).","journal-title":"J Exp Clin Cancer Res"},{"key":"80592_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41392-020-00217-4","volume":"5","author":"Y Xie","year":"2020","unstructured":"Xie, Y. et al. Action mechanisms and research methods of tRNA-derived small RNAs. Signal Transduct Target Ther 5, 109 (2020).","journal-title":"Signal Transduct Target Ther"},{"key":"80592_CR11","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1111\/cas.15505","volume":"113","author":"D Liu","year":"2022","unstructured":"Liu, D. et al. Transfer RNA-derived fragment 5\u2019tRF-Gly promotes the development of hepatocellular carcinoma by direct targeting of carcinoembryonic antigen-related cell adhesion molecule 1. Cancer Sci 113, 3476\u20133488 (2022).","journal-title":"Cancer Sci"},{"key":"80592_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1186\/s12935-021-02102-8","volume":"21","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. et al. Gly-tRF enhances LCSC-like properties and promotes HCC cells migration by targeting NDFIP2. Cancer Cell Int 21, 502 (2021).","journal-title":"Cancer Cell Int"},{"key":"80592_CR13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11684-022-0966-6","volume":"17","author":"C Wu","year":"2023","unstructured":"Wu, C. et al. 5\u2019-tiRNA-Gln inhibits hepatocellular carcinoma progression by repressing translation through the interaction with eukaryotic initiation factor 4A-I. Front Med 17, 476\u2013492 (2023).","journal-title":"Front Med"},{"key":"80592_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41420-021-00647-1","volume":"7","author":"X Li","year":"2021","unstructured":"Li, X. et al. tRNA-derived small RNAs: novel regulators of cancer hallmarks and targets of clinical application. Cell Death Discov 7, 249 (2021).","journal-title":"Cell Death Discov"},{"key":"80592_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12977","volume":"54","author":"T Zong","year":"2021","unstructured":"Zong, T. et al. tsRNAs: Novel small molecules from cell function and regulatory mechanism to therapeutic targets. Cell Prolif 54, e12977 (2021).","journal-title":"Cell Prolif"},{"key":"80592_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.semcancer.2021.05.024","volume":"75","author":"J Li","year":"2021","unstructured":"Li, J., Zhu, L., Cheng, J. & Peng, Y. Transfer RNA-derived small RNA: A rising star in oncology. Semin Cancer Biol 75, 29\u201337 (2021).","journal-title":"Semin Cancer Biol"},{"key":"80592_CR17","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s11684-022-0920-7","volume":"16","author":"S Zhan","year":"2022","unstructured":"Zhan, S. et al. Serum mitochondrial tsRNA serves as a novel biomarker for hepatocarcinoma diagnosis. Front Med 16, 216\u2013226 (2022).","journal-title":"Front Med"},{"key":"80592_CR18","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mc.23592","volume":"62","author":"X Li","year":"2023","unstructured":"Li, X., Zhang, Y., Li, Y., Gu, X. & Ju, S. A comprehensive evaluation of serum tRF-29-R9J8909NF5JP as a novel diagnostic and prognostic biomarker for gastric cancer. Mol Carcinog 62, 1504\u20131517 (2023).","journal-title":"Mol Carcinog"},{"key":"80592_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12943-021-01389-5","volume":"20","author":"F Jin","year":"2021","unstructured":"Jin, F. et al. A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer. Mol Cancer 20, 95 (2021).","journal-title":"Mol Cancer"},{"key":"80592_CR20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s11864-023-01098-9","volume":"24","author":"B Alawyia","year":"2023","unstructured":"Alawyia, B. & Constantinou, C. Hepatocellular carcinoma: A narrative review on current knowledge and future prospects. Curr Treat Options Oncol 24, 711\u2013724 (2023).","journal-title":"Curr Treat Options Oncol"},{"key":"80592_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24823","volume":"37","author":"S Tian","year":"2023","unstructured":"Tian, S., Chen, Y., Zhang, Y. & Xu, X. Clinical value of serum AFP and PIVKA-II for diagnosis, treatment and prognosis of hepatocellular carcinoma. J Clin Lab Anal 37, e24823 (2023).","journal-title":"J Clin Lab Anal"},{"key":"80592_CR22","doi-asserted-by":"publisher","first-page":"8868370","DOI":"10.1155\/2021\/8868370","volume":"2021","author":"F Xu","year":"2021","unstructured":"Xu, F. et al. The diagnostic value of serum PIVKA-II alone or in combination with AFP in Chinese hepatocellular carcinoma patients. Dis Markers 2021, 8868370 (2021).","journal-title":"Dis Markers"},{"key":"80592_CR23","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel, A., Meyer, T., Sapisochin, G., Salem, R. & Saborowski, A. Hepatocellular carcinoma. Lancet 400, 1345\u20131362 (2022).","journal-title":"Lancet"},{"key":"80592_CR24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5582\/bst.2021.01094","volume":"15","author":"Y Sugawara","year":"2021","unstructured":"Sugawara, Y. & Hibi, T. Surgical treatment of hepatocellular carcinoma. Biosci Trends 15, 138\u2013141 (2021).","journal-title":"Biosci Trends"},{"key":"80592_CR25","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.2217\/fon-2020-0758","volume":"17","author":"PR Galle","year":"2021","unstructured":"Galle, P. R., Dufour, J. F., Peck-Radosavljevic, M., Trojan, J. & Vogel, A. Systemic therapy of advanced hepatocellular carcinoma. Future Oncol 17, 1237\u20131251 (2021).","journal-title":"Future Oncol"},{"key":"80592_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24658","volume":"36","author":"C Liu","year":"2022","unstructured":"Liu, C. et al. Serum non-coding RNAs for diagnosis and stage of liver fibrosis. J Clin Lab Anal 36, e24658 (2022).","journal-title":"J Clin Lab Anal"},{"key":"80592_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.639963","volume":"12","author":"R Liu","year":"2021","unstructured":"Liu, R. et al. Identification of plasma hsa_circ_0005397 and combined with serum AFP, AFP-L3 as potential biomarkers for hepatocellular carcinoma. Front Pharmacol 12, 639963 (2021).","journal-title":"Front Pharmacol"},{"key":"80592_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118193","volume":"259","author":"NE El-Ashmawy","year":"2020","unstructured":"El-Ashmawy, N. E., Hussien, F. Z., El-Feky, O. A., Hamouda, S. M. & Al-Ashmawy, G. M. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic\/prognostic non-invasive biomarkers for breast cancer. Life Sci 259, 118193 (2020).","journal-title":"Life Sci"},{"key":"80592_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.843598","volume":"12","author":"BF Fu","year":"2022","unstructured":"Fu, B. F. & Xu, C. Y. Transfer RNA-derived small RNAs: Novel regulators and biomarkers of cancers. Front Oncol 12, 843598 (2022).","journal-title":"Front Oncol"},{"key":"80592_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s10020-022-00491-8","volume":"28","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y., Gu, X., Qin, X., Huang, Y. & Ju, S. Evaluation of serum tRF-23-Q99P9P9NDD as a potential biomarker for the clinical diagnosis of gastric cancer. Mol Med 28, 63 (2022).","journal-title":"Mol Med"},{"key":"80592_CR31","doi-asserted-by":"publisher","first-page":"8438726","DOI":"10.1155\/2022\/8438726","volume":"2022","author":"X Gu","year":"2022","unstructured":"Gu, X., Zhang, Y., Huang, Y. & Ju, S. Comprehensive evaluation of serum tRF-17-WS7K092 as a promising biomarker for the diagnosis of gastric cancer. J Oncol 2022, 8438726 (2022).","journal-title":"J Oncol"},{"key":"80592_CR32","first-page":"837","volume":"11","author":"M Xue","year":"2021","unstructured":"Xue, M. et al. Serum tRNA-derived small RNAs as potential novel diagnostic biomarkers for pancreatic ductal adenocarcinoma. Am J Cancer Res 11, 837\u2013848 (2021).","journal-title":"Am J Cancer Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80592-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80592-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80592-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T03:07:46Z","timestamp":1732158466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-80592-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["80592"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-80592-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"22 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Clinical samples were collected after informed consent was obtained from the subjects, and studies involving human subjects were reviewed and approved by the Ethics Committees of the Affiliated Hospital of Nantong University (Number: 2019-L071).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"28834"}}